Descrizione

Treatment response rates in infants with constipation randomized to fructooligosaccharide or placebo groups. The clinical trial results assess the therapeutic benefit of FOS in improving bowel function.

Figure 3

Chart

Source Paper

Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing the Effect of Fructooligosaccharides in Infants with Constipation.

Nutrients (2018)

PMID: 30388751

DOI: 10.3390/nu10111602

Cite This Figure

![Figure 3: Treatment response rates in infants with constipation randomized to fructooligosaccharide or placebo groups. The clinical trial results assess the therapeutic benefit of FOS in improving bowel function.]()

> Source: Daniela da Silva Souza et al. "Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing t." *Nutrients*, 2018. PMID: [30388751](https://pubmed.ncbi.nlm.nih.gov/30388751/)

<figure>
  <img src="" alt="Treatment response rates in infants with constipation randomized to fructooligosaccharide or placebo groups. The clinical trial results assess the therapeutic benefit of FOS in improving bowel function." />
  <figcaption>Figure 3. Treatment response rates in infants with constipation randomized to fructooligosaccharide or placebo groups. The clinical trial results assess the therapeutic benefit of FOS in improving bowel function.<br>  Source: Daniela da Silva Souza et al. "Randomized, Double-Blind, Placebo-Controlled Parallel Clinical Trial Assessing t." <em>Nutrients</em>, 2018. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/30388751/">30388751</a></figcaption>
</figure>

Evidenze correlate

Fructooligosaccharides (FOS) per Chronic Constipation

Grado C · 4 studi